Search
for
Sort by
Research 30 of 32
- Increased Circulating CXCL10 in Non-Segmental Vitiligo Concomitant with Autoimmune Thyroid Disease and Alopecia Areata
- Segmental Vitiligo
- Clinical Predictors of Outcome in Nonsegmental Vitiligo: A Prospective Cohort Study
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.
- Advancing the Understanding and Management of Segmental Vitiligo and Co‐Existing Pigmentary Disorders
- EFFECT OF PLASMATHERAPY ON THE IMMUNE STATUS OF PATIENTS WITH VITILIGO
- Melanocytes and Vitiligo (and Hair Graying)
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Liposomal systems as drug delivery vehicles for dermal and transdermal applications
- A symphony of signals: the intricate role of lncRNAs in dermatological disorders
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- Fractional CO₂ laser combined with topical compound betamethasone for Vitiligo-Associated Leukotrichia: a retrospective study of 13 patients with limited effectiveness
- Surgical treatment of vitiligo
- Microneedle-Based Approaches for Skin Disease Treatment
- Vitiligo - Part 2 - classification, histopathology and treatment
- Platelet‐rich plasma injection versus combined fractional carbon dioxide laser with platelet‐rich plasma in treatment of vitiligo: A comparative study
- Vitiligo—Current Treatment Options and Future Perspectives
- Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- Evaluation of E- cadherin and Hydrogen Peroxide in Skin of Patients with Vitiligo
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Serum brain‐derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case–control study
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- DSP c.6310delA p.(Thr2104Glnfs*12) associates with arrhythmogenic cardiomyopathy, increased trabeculation, curly hair, and palmoplantar keratoderma
- Repigmentation Competence in Vitiligo: Integrating Immune, Regulatory, Regenerative, and Microenvironmental Axes
- Vitiligo and Its Mimics in Childhood: A Diagnostic Framework for Hypopigmented Disorders
- 186 Mechanistic insights into Ritlecitinib-mediated immunomodulation in Alopecia Areata